Tag Archives: Japan

Seizing Academic Breakthroughs in Japan

Asia2013_115x76_Thumbnail copy

Japanese universities and universities around the Asia Pacific region are entering into unique evolving partnerships with biopharmaceutical companies. Universities are also exploring incubator and other models with company partners to deliver the next wave of biotechnology innovations. With a focus on collaborative projects between industry and academia, this year’s BIO Asia conference will attract universities and national/public institutes and their biopharma partners to come together to discuss their latest partnering models, an integral growth opportunity Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Plenary Sessions Announced for the 12th Annual BIO Asia International Conference

logo

This year’s BIO Asia International Conference has tripled the educational programming content to offer a superior experience for Japanese companies as well as global emerging biotech/pharma companies. In addition to the keynote speeches by Dr. Tatsuya Kondo, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA); Osamu Nagayama, Chairman & CEO, Chugai Pharmaceutical Co., Ltd. and President, Japan Bioindustry Association; and Flemming Ornskov, MD, CEO, Shire, the 2015 BIO Asia program will feature many great panel Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Submits Comments on “Myriad” PTO Patent Guidance

Supreme Court - Phil Roeder

On July 31st, BIO, alongside a group of international bioindustry trade associations submitted comments to the United States Patent and Trademark Office regarding their March 4, 2014 Guidance on patent subject matter eligibility. Representing associations from Japan, Australia, Canada, the UK, Germany, Spain, Portugal Belgium, the Netherlands and others, the comments reflect a deep concern among the international community regarding how the PTO is interpreting the Supreme Court’s recent decisions in Mayo v. Prometheus and Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Patent Utility Requirements for Biopharmaceutical Inventions: How Much is Enough?

Credit: Andrea Sivarsson

A debate between the innovative and generic perspectives on pharmaceutical patent law in Canada, moderated by David Kappos, will be held in Chicago on Monday April 22nd from 2:30-3:30pm in room S404A at this year’s BIO International Convention. Former Undersecretary of Commerce for Intellectual Property and USPTO Director David J. Kappos will moderate a panel of legal experts who will discuss recent developments in the area of patent utility and its implications for biopharmaceutical innovation.  Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

The Year Ahead for Business Development Events

BIO China

2013 is officially here (insert stale End-of-the-World joke). And as such, planning has been in full effect for BIO events. Here’s a recap of what’s coming up in the next few months. BIO’s in San Fran for JPM As a BIO member service, companies can schedule private meeting space for free during JP Morgan. This year, meetings will take place at The Palace Hotel, on the 5th floor. You can also find Celia, Dave, Kirsten Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,